Short-Term Metformin Treatment Enriches Bacteroides dorei in an Obese Liver Steatosis Zucker Rat Model

Short-Term Metformin Treatment Enriches Bacteroides dorei in an Obese Liver Steatosis Zucker Rat Model

Obesity is the leading cause of health-related diseases in the United States and World. Previously, we reported that obesity can change gut microbiota using the Zucker rat model. Metformin is an oral anti-hyperglycemic agent approved by the FDA to treat type 2 diabetes (T2D) in adults and children o...

Full description

Bibliographic Details
Main Authors: Michael S. Robeson, Kanishka Manna, Christopher Randolph, Stephanie Byrum, Reza Hakkak
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Microbiology
Subjects:
obesity
metformin
Bacteroides dorei
Zucker rat
gut microbiota
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2022.834776/full

Similar Items

Similar Items